Verve Therapeutics (VERV)
NASDAQ:VERV
US Market
Holding VERV?
Track your performance easily

Verve Therapeutics (VERV) Financial Statements

468 Followers

Verve Therapeutics Financial Overview

Verve Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.875; its P/E ratio is -2.34; Verve Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.68. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 5.70M$ 5.14M---
Gross Profit-----
EBIT$ -56.84M-$ -45.69M$ -53.81M$ -51.98M
EBITDA$ -55.21M-$ -47.71M$ -56.17M$ -54.70M
Net Income Common Stockholders$ -48.74M$ -48.35M$ -45.79M$ -53.98M$ -51.98M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 606.37M$ 623.95M$ 485.23M$ 462.48M$ 508.69M
Total Assets$ 732.36M$ 752.69M$ 612.41M$ 589.13M$ 634.38M
Total Debt$ 73.67M$ 74.91M$ 76.81M$ 77.86M$ 80.11M
Net Debt$ -532.69M$ -549.04M$ -408.42M$ -384.61M$ -428.58M
Total Liabilities$ 149.29M$ 153.19M$ 152.04M$ 123.91M$ 124.90M
Stockholders Equity$ 583.07M$ 599.50M$ 460.37M$ 465.22M$ 509.48M
Cash Flow-
Free Cash Flow$ -43.52M-$ -12.87M$ -50.62M$ -52.47M
Operating Cash Flow$ -43.08M$ -40.68M$ -11.81M$ -47.96M$ -49.10M
Investing Cash Flow$ -41.63M$ -8.89M$ -11.83M$ 33.02M$ 15.39M
Financing Cash Flow$ 22.73M$ 177.38M$ 31.92M$ 1.23M$ 2.04M
Currency in USD

Verve Therapeutics Earnings and Revenue History

Verve Therapeutics Debt to Assets

Verve Therapeutics Cash Flow

Verve Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis